CDC Awards Contract to ACMT to Obtain Critical Drug Overdose Data from the Toxicology Investigators Consortium
The U.S. Centers for Disease Control and Prevention (CDC) has awarded the American College of Medical Toxicology (ACMT) a contract for access to data from ACMT’s Toxicology Investigators Consortium (ToxIC) Patient Registry, as part of CDC’s National Center for Injury Prevention and Control (NCIPC) Division of Overdose Prevention (DOP) to enhance drug overdose surveillance.
ACMT’s ToxIC is a unique multicenter toxico-surveillance and research network comprised of physicians specifically qualified in the field of medical toxicology. Since the network’s establishment in 2010, there have been over 73,000 cases recorded into ToxIC’s Patient Registry from 40 participating sites across the United States comprised of more than 60 hospitals and clinics. This registry was designed to provide accurate and reliable data on overdose and adverse effects arising from exposures to medications, drugs of abuse, natural substances, metals, pesticides, or other chemical substances.
“ACMT is very honored to receive this contract from CDC for this important project related to drug overdose surveillance,” said Dr. Paul M. Wax, ACMT’s Executive Director and co-founder of ToxIC. “For over a decade, ACMT has worked diligently to develop the ToxIC Patient Registry as a useful tool for overdose surveillance. Particularly now, in the midst of the opioid overdose epidemic we anticipate this collaboration will deliver critical data that could improve public health decision making.”
This collaboration is expected to help CDC better characterize drug overdose and is consistent with CDC’s mission to provide leadership in preventing and controlling injuries.